• Published On : Jun-2017 |
  • Pages : 256 Pages |
  • Format :

1. Preface

2. Research Methodology

3. Assumptions & Acronyms Used

4. Market Definition

5. Market Taxonomy

6. Executive Summary

7. Market Dynamics
   7.1. Macro-economic Dynamics
   7.2. Drivers 
   7.3. Restraints
   7.4. Opportunities
   7.5. Trends

8. Major Deals and Regulations: API CDMO 

9. Drug Pipeline Analysis
   9.1. Oligonucleotide Drug Pipeline Analysis
   9.2. Peptides Drug Pipeline Analysis
   9.3. Steroidal Drug Pipeline Analysis
   9.4. High Potency API Drug Pipeline Analysis

10. Primary Responses and Interpretation
   10.1. Primary Respondents by Region
   10.2. Primary (KOL) Outlooks

11. Global Active Pharmaceutical Ingredients Market, by API Type, 2011-2025
   11.1. Overview
   11.2. Market Value Share & BPS Analysis, by API Type, 2011- 2025
   11.3. Market Historic Market Value (US$ Mn) & Y-o-Y Growth (%), by API Type, 2011- 2025
         11.3.1. Small Molecules
                 11.3.1.1. Controlled Substances
                           11.3.1.1.1. Natural Opioids
                           11.3.1.1.2. Semi-synthetic/Synthetic Opioids
                 11.3.1.2. Non-Controlled Substances
                           11.3.1.2.1. NSAIDs
                           11.3.1.2.2. Anti-infective
                           11.3.1.2.3. Antimicrobial
                           11.3.1.2.4. Oral anti-diabetics 
                           11.3.1.2.5. Anti-hypertensive 
                           11.3.1.2.6. Others
                 11.3.1.3. HPAPI
         11.3.2. Peptides & Oligonucleotides
         11.3.3. Carbohydrate Drugs
         11.3.4. Steroidal Drugs
   11.4. Market Attractiveness Analysis by API Type

12. Global Active Pharmaceutical Ingredients Market, by Region, 2011-2025
   12.1. Overview
   12.2. Market Value Share & BPS Analysis, by Region, 2011- 2025
   12.3. Market Historic Market Value (US$ Mn) & Y-o-Y Growth (%), by Region, 2011- 2025
         12.3.1. North America
         12.3.2. Latin America
         12.3.3. Europe
         12.3.4. Asia Pacific
         12.3.5. Rest of World
   12.4. Market Attractiveness Analysis by Region

13. North America Active Pharmaceutical Ingredients Market Revenue, 2011- 2025
   13.1. Overview
   13.2. Market Value Share & BPS Analysis, by API Type, 2011- 2025
   13.3. Market Historic Market Value (US$ Mn) & Y-o-Y Growth (%), by API Type, 2011- 2025
         13.3.1. Small Molecules
                 13.3.1.1. Controlled Substances
                           13.3.1.1.1. Natural Opioids
                           13.3.1.1.2. Semi-synthetic/Synthetic Opioids
                 13.3.1.2. Non-Controlled Substances
                           13.3.1.2.1. NSAIDs
                           13.3.1.2.2. Anti-infective
                           13.3.1.2.3. Antimicrobial
                           13.3.1.2.4. Oral anti-diabetics 
                           13.3.1.2.5. Anti-hypertensive 
                           13.3.1.2.6. Others
                 13.3.1.3. HPAPI
         13.3.2. Peptides & Oligonucleotides
         13.3.3. Carbohydrate Drugs
         13.3.4. Steroidal Drugs
   13.4. Market Attractiveness Analysis by Country
   13.5. North America API Market Value, by API Type, 2011–2025
   13.6. North America API Market Value, by Country, 2011–2025
   13.7. Key Market Trends: North America API Market

14. Latin America Active Pharmaceutical Ingredients Market Revenue, 2011- 2025
   14.1. Overview
   14.2. Market Value Share & BPS Analysis, by API Type, 2011- 2025
   14.3. Market Historic Market Value (US$ Mn) & Y-o-Y Growth (%), by API Type, 2011- 2025
         14.3.1. Small Molecules
                 14.3.1.1. Controlled Substances
                           14.3.1.1.1. Natural Opioids
                           14.3.1.1.2. Semi-synthetic/Synthetic Opioids
                 14.3.1.2. Non-Controlled Substances
                           14.3.1.2.1. NSAIDs
                           14.3.1.2.2. Anti-infective
                           14.3.1.2.3. Antimicrobial
                           14.3.1.2.4. Oral anti-diabetics 
                           14.3.1.2.5. Anti-hypertensive 
                           14.3.1.2.6. Others
                 14.3.1.3. HPAPI
         14.3.2. Peptides & Oligonucleotides
         14.3.3. Carbohydrate Drugs
         14.3.4. Steroidal Drugs
   14.4. Market Attractiveness Analysis by Country
   14.5. Latin America API Market Value, by API Type, 2011–2025
   14.6. Latin America API Market Value, by Country, 2011–2025
   14.7. Key Market Trends: Latin America API Market

15. Europe Active Pharmaceutical Ingredients Market Revenue, 2011- 2025
   15.1. Overview
   15.2. Market Value Share & BPS Analysis, by API Type, 2011- 2025
   15.3. Market Historic Market Value (US$ Mn) & Y-o-Y Growth (%), by API Type, 2011- 2025
         15.3.1. Small Molecules
                 15.3.1.1. Controlled Substances
                           15.3.1.1.1. Natural Opioids
                           15.3.1.1.2. Semi-synthetic/Synthetic Opioids
                 15.3.1.2. Non-Controlled Substances
                           15.3.1.2.1. NSAIDs
                           15.3.1.2.2. Anti-infective
                           15.3.1.2.3. Antimicrobial
                           15.3.1.2.4. Oral anti-diabetics 
                           15.3.1.2.5. Anti-hypertensive 
                           15.3.1.2.6. Others
                 15.3.1.3. HPAPI
         15.3.2. Peptides & Oligonucleotides
         15.3.3. Carbohydrate Drugs
         15.3.4. Steroidal Drugs
   15.4. Market Attractiveness Analysis by Country
   15.5. Europe API Market Value, by API Type, 2011–2025
   15.6. Europe API Market Value, by Country, 2011–2025
   15.7. Key Market Trends: Europe API Market

16. APAC Active Pharmaceutical Ingredients Market Revenue, 2011- 2025
   16.1. Overview
   16.2. Market Value Share & BPS Analysis, by API Type, 2011- 2025
   16.3. Market Historic Market Value (US$ Mn) & Y-o-Y Growth (%), by API Type, 2011- 2025
         16.3.1. Small Molecules
                 16.3.1.1. Controlled Substances
                           16.3.1.1.1. Natural Opioids
                           16.3.1.1.2. Semi-synthetic/Synthetic Opioids
                 16.3.1.2. Non-Controlled Substances
                           16.3.1.2.1. NSAIDs
                           16.3.1.2.2. Anti-infective
                           16.3.1.2.3. Antimicrobial
                           16.3.1.2.4. Oral anti-diabetics 
                           16.3.1.2.5. Anti-hypertensive 
                           16.3.1.2.6. Others
                 16.3.1.3. HPAPI
         16.3.2. Peptides & Oligonucleotides
         16.3.3. Carbohydrate Drugs
         16.3.4. Steroidal Drugs
   16.4. Market Attractiveness Analysis by Country
   16.5. APAC API Market Value, by API Type, 2011–2025
   16.6. APAC API Market Value, by Country, 2011–2025
   16.7. Key Market Trends: APAC API Market

17. Rest of World Active Pharmaceutical Ingredients Market Revenue, 2011- 2025
   17.1. Overview
   17.2. Market Value Share & BPS Analysis, by API Type, 2011- 2025
   17.3. Market Historic Market Value (US$ Mn) & Y-o-Y Growth (%), by API Type, 2011- 2025
         17.3.1. Small Molecules
                 17.3.1.1. Controlled Substances
                           17.3.1.1.1. Natural Opioids
                           17.3.1.1.2. Semi-synthetic/Synthetic Opioids
                 17.3.1.2. Non-Controlled Substances
                           17.3.1.2.1. NSAIDs
                           17.3.1.2.2. Anti-infective
                           17.3.1.2.3. Antimicrobial
                           17.3.1.2.4. Oral anti-diabetics 
                           17.3.1.2.5. Anti-hypertensive 
                           17.3.1.2.6. Others
                 17.3.1.3. HPAPI
         17.3.2. Peptides & Oligonucleotides
         17.3.3. Carbohydrate Drugs
         17.3.4. Steroidal Drugs
   17.4. Market Attractiveness Analysis by Country
   17.5. RoW API Market Value, by API Type, 2011–2025
   17.6. RoW API Market Value, by Country, 2011–2025
   17.7. Key Market Trends: RoW API Market

18. Company Profile
   18.1. Small Molecule API CDMO
         18.1.1. Johnson Matthey
         18.1.2. Siegfried
         18.1.3. Almac
   18.2. Peptide API
         18.2.1. PolyPeptide Laboratories
         18.2.2. AmbioPharm, Inc.
         18.2.3. Corden Pharma
         18.2.4. Pepscan
         18.2.5. BCN peptide
         18.2.6. Provence Technologies Groups
         18.2.7. SennChemicals AG
   18.3. Oligonucleotide API
         18.3.1. Avecia OligoMedicines 
         18.3.2. Santaris Pharma  - acquired by Roche in 2014 
         18.3.3. ST Pharm Oligo Center 
         18.3.4. Cepia Sanofi 
         18.3.5. Biospring
   18.4. Steroid API
         18.4.1. Pfizer CenterSource
         18.4.2. Symbiotec Pharma Lab Pvt. Ltd. 
         18.4.3. Gadea Grupo Farmacéutico
         18.4.4. STEROID S.p.A. 
         18.4.5. Dolder AG 
         18.4.6. Dalton Pharma Services
         18.4.7. FarmaBios Spa
   18.5. Carbohydrate API
         18.5.1. Dextra Laboratories Limited
         18.5.2. GlycoSyn 
         18.5.3. Inalco Pharma
         18.5.4. Sussex Research
         18.5.5. Pfanstiehl, Inc. 
   18.6. Controlled Substance
         18.6.1. Noramco, Inc.
         18.6.2. Johnson Matthey
         18.6.3. Siegfried
         18.6.4. Rhodes Technologies
   18.7. HPAPI
         18.7.1. Ash Stevens
         18.7.2. Fermion (public)
         18.7.3. FARMHISPANIA GROUP
         18.7.4. Olon SpA
         18.7.5. Lonza Group


List of Tables

Table 01: Global Pharmaceutical Market Indicators 
Table 02: Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011-2025
Table 03: North America Active Pharmaceutical Ingredient Market Value (US$ Bn), by Region, 2011–2025
Table 04: North America Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011–2025
Table 05: North America Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011–2025
Table 06: Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011–2025
Table 07: Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011–2025
Table 08: Europe Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011–2025
Table 09: Europe Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011–2025
Table 10: Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011–2025
Table 11: Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011–2025
Table 12: Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn), by API Type, 2011–2025
Table 13: Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn), by Country, 2011–2025


List of Figure

Figure 01: Global Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth Forecast, 2014–2024
Figure 02: Peptide Drug Pipeline Analysis
Figure 03: Peptide Drug Pipeline Analysis by Companies,
Figure 04: Steroidal Drug Pipeline Analysis by Developmental Phase, 2016
Figure 05: Steroidal Drug Pipeline Analysis
Figure 06: High Potency Drug Pipeline Analysis by Developmental Phase, 2016
Figure 07: High Potency Drug Pipeline Analysis
Figure 08: Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by API Type, 2017 & 2025
Figure 09: Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by API Type, 2015–2025
Figure 10: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011–2016
Figure 11: Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016–2025
Figure 12: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011–2016
Figure 13: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016–2025
Figure 14: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011–2016
Figure 15: Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016–2025
Figure 16: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011–2016
Figure 17: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016–2025
Figure 18: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011–2016
Figure 19: Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016–2025
Figure 20: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011–2016
Figure 21: Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016–2025
Figure 22: Active Pharmaceutical Ingredient Market Attractiveness Analysis, by Product Type, 2016–2025
Figure 23: Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by API Type, 2017 & 2025
Figure 24: Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by API Type, 2016–2025
Figure 25: North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011–2016
Figure 26: North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), 2016–2025
Figure 27: Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011–2016
Figure 28: Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2016–2025
Figure 29: Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011–2016
Figure 30: Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), 2016–2025
Figure 31: APAC Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2011–2016
Figure 32: APAC Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2016–2025
Figure 33: RoW Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), 2016–2025
Figure 34: RoW Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), 2016–2025
Figure 35: Global Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
Figure 36: North America Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2016 & 2025
Figure 37: North America Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016–2025
Figure 38: North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011–2016
Figure 39: North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016–2025
Figure 40: North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011–2016
Figure 41: North America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016–2025
Figure 42: North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011–2016
Figure 43: North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016–2025
Figure 44: North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011–2016
Figure 45: North America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016–2025
Figure 46: North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011–2016
Figure 47: North America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016–2025
Figure 48: North America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011–2016
Figure 49: North America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016–2025
Figure 50: North America Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
Figure 51: Latin America Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2017 & 2025
Figure 52: Latin America Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016–2025
Figure 53: Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011–2016
Figure 54: Latin America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016–2025
Figure 55: Latin America Active Pharmaceutical Ingredient Historic Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011–2016
Figure 56: Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016–2025
Figure 57: Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011–2016
Figure 58: Latin America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016–2025
Figure 59: Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011–2016
Figure 60: Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016–2025
Figure 61: Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011–2016
Figure 62: Latin America Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016–2025
Figure 63: Latin America Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011–2016
Figure 64: Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016–2025
Figure 65: Latin America Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
Figure 66: Europe Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2017 & 2025
Figure 67: Europe Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016–2025
Figure 68: Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011–2016
Figure 69: Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016–2025
Figure 70: Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011–2016
Figure 71: Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016–2025
Figure 72: Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011–2016
Figure 73: Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016–2025
Figure 74: Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011–2016
Figure 75: Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016–2025
Figure 76: Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011–2016
Figure 77: Europe Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016–2025
Figure 78: Europe Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011–2016
Figure 79: Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016–2025
Figure 80: Europe Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
Figure 81: Asia Pacific Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2017 & 2025
Figure 82: Asia Pacific Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016–2025
Figure 83: Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011–2016
Figure 84: Asia Pacific Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016–2025
Figure 85: Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011–2016
Figure 86: Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016–2025
Figure 87: Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011–2016
Figure 88: Asia Pacific Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016–2025
Figure 89: Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011–2016
Figure 90: Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016–2025
Figure 91: Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011–2016
Figure 92: Asia Pacific Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016–2025
Figure 93: Asia Pacific Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011–2016
Figure 94: Asia Pacific Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016–2025
Figure 95: Asia Pacific Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025
Figure 96: Rest of World Active Pharmaceutical Ingredient Market Value Share & BPS Analysis, by Country, 2016 & 2025
Figure 97: Rest of World Active Pharmaceutical Ingredient Market Y-o-Y Growth Comparison, by Country, 2016–2025
Figure 98: Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2011–2016
Figure 99: Rest of World Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Controlled Substances Segment, 2016–2025
Figure 100: Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2011–2016
Figure 101: Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Non controlled Substances Segment, 2016–2025
Figure 102: Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2011–2016
Figure 103: Rest of World Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Peptides & Oligonucleotides Segment, 2016–2025
Figure 104: Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2011–2016
Figure 105: Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by HPAPI Segment, 2016–2025
Figure 106: Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2011–2016
Figure 107: Rest of World Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn) & Y-o-Y Growth (%), by Carbohydrate Drugs Segment, 2016–2025
Figure 108: Rest of World Active Pharmaceutical Ingredient Historic Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2011–2016
Figure 109: Rest of World Active Pharmaceutical Ingredient Market Value (US$ Bn) & Y-o-Y Growth (%), by Steroidal Drugs Segment, 2016–2025
Figure 110: Rest of World Active Pharmaceutical Ingredients Market Attractiveness Index, 2016-2025